Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravid Straussman

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Nature Genetics|January 4, 2007
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancerYeshayahu Schlesinger, Ravid Straussman, Ilana Keshet, et al.
Cancer Biology & Therapy|March 23, 2018
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapyAlbert Grinshpun, Nancy Gavert, Roy Zvi Granit, et al.
Nature Communications|June 28, 2020
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progressionLishay Parhi, Tamar Alon-Maimon, Asaf Sol, et al.
The Journal of Experimental Medicine|February 14, 2018
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancerKevin Shee, Wei Yang, John W Hinds, et al.
Gastroenterology|July 13, 2020
High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier FunctionInna Grosheva, Danping Zheng, Maayan Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Journal of Immunology Research|June 14, 2016
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 BlockadeMichal Lotem, Sharon Merims, Stephen Frank, et al.
Cancer Discovery|April 29, 2014
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitorsDavid J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, et al.
Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Nature Genetics|January 4, 2007
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancerYeshayahu Schlesinger, Ravid Straussman, Ilana Keshet, et al.
Cancer Biology & Therapy|March 23, 2018
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapyAlbert Grinshpun, Nancy Gavert, Roy Zvi Granit, et al.
Nature Communications|June 28, 2020
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progressionLishay Parhi, Tamar Alon-Maimon, Asaf Sol, et al.
The Journal of Experimental Medicine|February 14, 2018
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancerKevin Shee, Wei Yang, John W Hinds, et al.
Gastroenterology|July 13, 2020
High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier FunctionInna Grosheva, Danping Zheng, Maayan Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Journal of Immunology Research|June 14, 2016
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 BlockadeMichal Lotem, Sharon Merims, Stephen Frank, et al.
Cancer Discovery|April 29, 2014
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitorsDavid J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, et al.
Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.
Pageof 5